Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;37(1):43-52.
doi: 10.1002/pd.4928. Epub 2016 Oct 25.

Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions

Affiliations

Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions

Lillian M Zwemer et al. Prenat Diagn. 2017 Jan.

Abstract

Objective: We tested the hypothesis that FMR1 expansions would result in global gene dysregulation as early as the second trimester of human fetal development.

Method: Using cell-free fetal RNA obtained from amniotic fluid supernatant and expression microarrays, we compared RNA levels in samples from fetuses with premutation or full mutation allele expansions with control samples.

Results: We found clear signals of differential gene expression relating to a variety of cellular functions, including ubiquitination, mitochondrial function, and neuronal/synaptic architecture. Additionally, among the genes showing differential gene expression, we saw links to related diseases of intellectual disability and motor function. Finally, within the unique molecular phenotypes established for each mutation set, we saw clear signatures of mitochondrial dysfunction and disrupted neurological function. Patterns of differential gene expression were very different in male and female fetuses with premutation alleles.

Conclusion: These results support a model for which genetic misregulation during fetal development may set the stage for late clinical manifestations of FMR1-related disorders. © 2016 John Wiley & Sons, Ltd.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, et al. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet. 1993;3:36–43. - PubMed
    1. Fridell RA, Benson RE, Hua J, et al. A nuclear role for the Fragile X mental retardation protein. EMBO J. 1996;15:5408–5414. - PMC - PubMed
    1. Ling S-C, Fahrner PS, Greenough WT, Gelfand VI. Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein. Proc Nat Acad Sci USA. 2004;101:17428–17433. - PMC - PubMed
    1. Dictenberg JB, Swanger SA, Antar LN, et al. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile x syndrome. Dev Cell. 2008;14:926–939. - PMC - PubMed
    1. Darnell JC, Van Driesche SJ, Zhang C, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146:247–261. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources